Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study

出版年份 2017 全文链接

标题

作者

关键词

IL23, IL22, Clinical Trial, Phase II

出版物

Volume 153, Issue 1, Pages 77-86.e6

出版商

Elsevier BV

发表日期

2017-04-06

DOI

10.1053/j.gastro.2017.03.049

联系作者

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now